The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
The House of Lords EU Home Affairs Sub-Committee has written to health secretary Matt Hancock asking for clarity on the government’s contingency preparations to ensure the UK has continued access to medicines and medical products in the event of a ‘no deal’ Brexit.
The government has announced plans to inject an extra £3.5 billion a year into primary and community healthcare by 2023/24, calling the investment a “historic commitment” to increasing the proportion of NHS funding spent on primary and community services.
MSD’s Keytruda should be funded on the NHS via the Cancer Drugs Fund for patients with the certain forms of lung cancer, according to draft guidance from the National Institute for Health and Care Excellence.
Over a quarter of UK pharmacists still don’t believe their skills are being properly utilised by the public, and just 5% think the UK public are aware of the level of expertise that they have, new research shows.
One third of patients with chronic obstructive pulmonary disease (COPD) feel they would receive better care if they had cancer, diabetes or heart disease, according to a new Chiesi-sponsored patient survey.